Dr. Bourla’s announcement was made via Twitter on the same day the FDA and CDC recommended the nation pause use of Johnson & Johnson’s COVID-19 vaccine. The FDA and CDC made the recommendation so they can review six reports of rare and serious blood clots in people who have received the shot.
Dr. Bourla said Pfizer has accelerated its COVID-19 vaccine production and will be able to fulfill the White House’s 300 million order two weeks before its due at the end of July.
More articles on pharmacy:
How Walgreens, CVS, states are handling the J&J vaccine pause
6 most reputable drugmakers
Biden: J&J pause won’t affect US vaccination pace
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
